Our study indicates that families carrying mutations in GRN or MAPT can present with disease that is clinically indistinguishable from probable AD even in specialist memory disorder clinics, which is analogous to the observations that “AD mutations” can present with frontotemporal lobar degeneration [61]–[63]. The gene discussed is MAPT; the disease is Alzheimer disease.